Report Cover

Global Personalized Medicine and Epigenomics Market 2021 by Company, Regions, Type and Application, Forecast to 2026


The Personalized Medicine and Epigenomics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Personalized Medicine and Epigenomics size is estimated to be USD xx million in 2025 from USD xx million in 2019, with a change XX% between 2019 and 2020. The global Personalized Medicine and Epigenomics market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Personalized Medicine and Epigenomics market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Reagents
    Kits
    Instruments
    Enzymes
    Services

Market segment by Application, can be divided into
    Oncology
    Non-Oncology
    Cancer Drug Technology

Market segment by players, this report covers
    Abbott Laboratories
    Affymetrix
    Agilent Technologies
    Astellas Pharmaceuticals
    BAYER AG
    Bio Vision
    Celgene Corp.
    Emd Millipore
    Epigenomics AG
    Epigentex
    Envivo Pharmaceuticals (Forum Pharmaceutricals)
    Gilead Sciences
    Glaxosmithkline
    Illumina Inc.
    Johnson & Johnson
    Karus Therapeutics Limited
    Laboratory Corp. Of America Holdings
    LES Laboratoires Servier
    Merck
    Naturewise Biotech & Medicals Corp.
    Novartis Pharma AG
    Oncolys Biopharma Inc.
    Orchid Chemicals & Pharmaceuticals Limited
    Progen Pharmaceuticals Limited
    Quest Diagnostics
    Roche Holding AG
    Rubicon Genomics
    Takeda Pharmaceutical Company Limited

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
    South America (Brazil, Argentina, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
    1.1 Product Overview and Scope of Personalized Medicine and Epigenomics
    1.2 Classification of Personalized Medicine and Epigenomics by Type
        1.2.1 Overview: Global Personalized Medicine and Epigenomics Market Size by Type: 2020 Versus 2021 Versus 2026
        1.2.2 Global Personalized Medicine and Epigenomics Revenue Market Share by Type in 2020
        1.2.3 Reagents
        1.2.4 Kits
        1.2.5 Instruments
        1.2.6 Enzymes
        1.2.7 Services
    1.3 Global Personalized Medicine and Epigenomics Market by Application
        1.3.1 Overview: Global Personalized Medicine and Epigenomics Market Size by Application: 2020 Versus 2021 Versus 2026
        1.3.2 Oncology
        1.3.3 Non-Oncology
        1.3.4 Cancer Drug Technology
    1.4 Global Personalized Medicine and Epigenomics Market Size & Forecast
    1.5 Global Personalized Medicine and Epigenomics Market Size and Forecast by Region
        1.5.1 Global Personalized Medicine and Epigenomics Market Size by Region: 2016 VS 2021 VS 2026
        1.5.2 Global Personalized Medicine and Epigenomics Market Size by Region, (2016-2021)
        1.5.3 North America Personalized Medicine and Epigenomics Market Size and Prospect (2016-2026)
        1.5.4 Europe Personalized Medicine and Epigenomics Market Size and Prospect (2016-2026)
        1.5.5 Asia-Pacific Personalized Medicine and Epigenomics Market Size and Prospect (2016-2026)
        1.5.6 South America Personalized Medicine and Epigenomics Market Size and Prospect (2016-2026)
        1.5.7 Middle East and Africa Personalized Medicine and Epigenomics Market Size and Prospect (2016-2026)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Personalized Medicine and Epigenomics Market Drivers
        1.6.2 Personalized Medicine and Epigenomics Market Restraints
        1.6.3 Personalized Medicine and Epigenomics Trends Analysis
2 Company Profiles
    2.1 Abbott Laboratories
        2.1.1 Abbott Laboratories Details
        2.1.2 Abbott Laboratories Major Business
        2.1.3 Abbott Laboratories Personalized Medicine and Epigenomics Product and Solutions
        2.1.4 Abbott Laboratories Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2019-2021)
        2.1.5 Abbott Laboratories Recent Developments and Future Plans
    2.2 Affymetrix
        2.2.1 Affymetrix Details
        2.2.2 Affymetrix Major Business
        2.2.3 Affymetrix Personalized Medicine and Epigenomics Product and Solutions
        2.2.4 Affymetrix Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2019-2021)
        2.2.5 Affymetrix Recent Developments and Future Plans
    2.3 Agilent Technologies
        2.3.1 Agilent Technologies Details
        2.3.2 Agilent Technologies Major Business
        2.3.3 Agilent Technologies Personalized Medicine and Epigenomics Product and Solutions
        2.3.4 Agilent Technologies Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2019-2021)
        2.3.5 Agilent Technologies Recent Developments and Future Plans
    2.4 Astellas Pharmaceuticals
        2.4.1 Astellas Pharmaceuticals Details
        2.4.2 Astellas Pharmaceuticals Major Business
        2.4.3 Astellas Pharmaceuticals Personalized Medicine and Epigenomics Product and Solutions
        2.4.4 Astellas Pharmaceuticals Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2019-2021)
        2.4.5 Astellas Pharmaceuticals Recent Developments and Future Plans
    2.5 BAYER AG
        2.5.1 BAYER AG Details
        2.5.2 BAYER AG Major Business
        2.5.3 BAYER AG Personalized Medicine and Epigenomics Product and Solutions
        2.5.4 BAYER AG Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2019-2021)
        2.5.5 BAYER AG Recent Developments and Future Plans
    2.6 Bio Vision
        2.6.1 Bio Vision Details
        2.6.2 Bio Vision Major Business
        2.6.3 Bio Vision Personalized Medicine and Epigenomics Product and Solutions
        2.6.4 Bio Vision Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2019-2021)
        2.6.5 Bio Vision Recent Developments and Future Plans
    2.7 Celgene Corp.
        2.7.1 Celgene Corp. Details
        2.7.2 Celgene Corp. Major Business
        2.7.3 Celgene Corp. Personalized Medicine and Epigenomics Product and Solutions
        2.7.4 Celgene Corp. Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2019-2021)
        2.7.5 Celgene Corp. Recent Developments and Future Plans
    2.8 Emd Millipore
        2.8.1 Emd Millipore Details
        2.8.2 Emd Millipore Major Business
        2.8.3 Emd Millipore Personalized Medicine and Epigenomics Product and Solutions
        2.8.4 Emd Millipore Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2019-2021)
        2.8.5 Emd Millipore Recent Developments and Future Plans
    2.9 Epigenomics AG
        2.9.1 Epigenomics AG Details
        2.9.2 Epigenomics AG Major Business
        2.9.3 Epigenomics AG Personalized Medicine and Epigenomics Product and Solutions
        2.9.4 Epigenomics AG Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2019-2021)
        2.9.5 Epigenomics AG Recent Developments and Future Plans
    2.10 Epigentex 
        2.10.1 Epigentex Details
        2.10.2 Epigentex Major Business
        2.10.3 Epigentex Personalized Medicine and Epigenomics Product and Solutions
        2.10.4 Epigentex Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2019-2021)
        2.10.5 Epigentex Recent Developments and Future Plans
    2.11 Envivo Pharmaceuticals (Forum Pharmaceutricals)
        2.11.1 Envivo Pharmaceuticals (Forum Pharmaceutricals) Details
        2.11.2 Envivo Pharmaceuticals (Forum Pharmaceutricals) Major Business
        2.11.3 Envivo Pharmaceuticals (Forum Pharmaceutricals) Personalized Medicine and Epigenomics Product and Solutions
        2.11.4 Envivo Pharmaceuticals (Forum Pharmaceutricals) Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2019-2021)
        2.11.5 Envivo Pharmaceuticals (Forum Pharmaceutricals) Recent Developments and Future Plans
    2.12 Gilead Sciences
        2.12.1 Gilead Sciences Details
        2.12.2 Gilead Sciences Major Business
        2.12.3 Gilead Sciences Personalized Medicine and Epigenomics Product and Solutions
        2.12.4 Gilead Sciences Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2019-2021)
        2.12.5 Gilead Sciences Recent Developments and Future Plans
    2.13 Glaxosmithkline
        2.13.1 Glaxosmithkline Details
        2.13.2 Glaxosmithkline Major Business
        2.13.3 Glaxosmithkline Personalized Medicine and Epigenomics Product and Solutions
        2.13.4 Glaxosmithkline Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2019-2021)
        2.13.5 Glaxosmithkline Recent Developments and Future Plans
    2.14 Illumina Inc.
        2.14.1 Illumina Inc. Details
        2.14.2 Illumina Inc. Major Business
        2.14.3 Illumina Inc. Personalized Medicine and Epigenomics Product and Solutions
        2.14.4 Illumina Inc. Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2019-2021)
        2.14.5 Illumina Inc. Recent Developments and Future Plans
    2.15 Johnson & Johnson
        2.15.1 Johnson & Johnson Details
        2.15.2 Johnson & Johnson Major Business
        2.15.3 Johnson & Johnson Personalized Medicine and Epigenomics Product and Solutions
        2.15.4 Johnson & Johnson Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2019-2021)
        2.15.5 Johnson & Johnson Recent Developments and Future Plans
    2.16 Karus Therapeutics Limited
        2.16.1 Karus Therapeutics Limited Details
        2.16.2 Karus Therapeutics Limited Major Business
        2.16.3 Karus Therapeutics Limited Personalized Medicine and Epigenomics Product and Solutions
        2.16.4 Karus Therapeutics Limited Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2019-2021)
        2.16.5 Karus Therapeutics Limited Recent Developments and Future Plans
    2.17 Laboratory Corp. Of America Holdings
        2.17.1 Laboratory Corp. Of America Holdings Details
        2.17.2 Laboratory Corp. Of America Holdings Major Business
        2.17.3 Laboratory Corp. Of America Holdings Personalized Medicine and Epigenomics Product and Solutions
        2.17.4 Laboratory Corp. Of America Holdings Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2019-2021)
        2.17.5 Laboratory Corp. Of America Holdings Recent Developments and Future Plans
    2.18 LES Laboratoires Servier
        2.18.1 LES Laboratoires Servier Details
        2.18.2 LES Laboratoires Servier Major Business
        2.18.3 LES Laboratoires Servier Personalized Medicine and Epigenomics Product and Solutions
        2.18.4 LES Laboratoires Servier Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2019-2021)
        2.18.5 LES Laboratoires Servier Recent Developments and Future Plans
    2.19 Merck
        2.19.1 Merck Details
        2.19.2 Merck Major Business
        2.19.3 Merck Personalized Medicine and Epigenomics Product and Solutions
        2.19.4 Merck Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2019-2021)
        2.19.5 Merck Recent Developments and Future Plans
    2.20 Naturewise Biotech & Medicals Corp.
        2.20.1 Naturewise Biotech & Medicals Corp. Details
        2.20.2 Naturewise Biotech & Medicals Corp. Major Business
        2.20.3 Naturewise Biotech & Medicals Corp. Personalized Medicine and Epigenomics Product and Solutions
        2.20.4 Naturewise Biotech & Medicals Corp. Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2019-2021)
        2.20.5 Naturewise Biotech & Medicals Corp. Recent Developments and Future Plans
    2.21 Novartis Pharma AG
        2.21.1 Novartis Pharma AG Details
        2.21.2 Novartis Pharma AG Major Business
        2.21.3 Novartis Pharma AG Personalized Medicine and Epigenomics Product and Solutions
        2.21.4 Novartis Pharma AG Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2019-2021)
        2.21.5 Novartis Pharma AG Recent Developments and Future Plans
    2.22 Oncolys Biopharma Inc.
        2.22.1 Oncolys Biopharma Inc. Details
        2.22.2 Oncolys Biopharma Inc. Major Business
        2.22.3 Oncolys Biopharma Inc. Personalized Medicine and Epigenomics Product and Solutions
        2.22.4 Oncolys Biopharma Inc. Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2019-2021)
        2.22.5 Oncolys Biopharma Inc. Recent Developments and Future Plans
    2.23 Orchid Chemicals & Pharmaceuticals Limited
        2.23.1 Orchid Chemicals & Pharmaceuticals Limited Details
        2.23.2 Orchid Chemicals & Pharmaceuticals Limited Major Business
        2.23.3 Orchid Chemicals & Pharmaceuticals Limited Personalized Medicine and Epigenomics Product and Solutions
        2.23.4 Orchid Chemicals & Pharmaceuticals Limited Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2019-2021)
        2.23.5 Orchid Chemicals & Pharmaceuticals Limited Recent Developments and Future Plans
    2.24 Progen Pharmaceuticals Limited
        2.24.1 Progen Pharmaceuticals Limited Details
        2.24.2 Progen Pharmaceuticals Limited Major Business
        2.24.3 Progen Pharmaceuticals Limited Personalized Medicine and Epigenomics Product and Solutions
        2.24.4 Progen Pharmaceuticals Limited Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2019-2021)
        2.24.5 Progen Pharmaceuticals Limited Recent Developments and Future Plans
    2.25 Quest Diagnostics
        2.25.1 Quest Diagnostics Details
        2.25.2 Quest Diagnostics Major Business
        2.25.3 Quest Diagnostics Personalized Medicine and Epigenomics Product and Solutions
        2.25.4 Quest Diagnostics Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2019-2021)
        2.25.5 Quest Diagnostics Recent Developments and Future Plans
    2.26 Roche Holding AG
        2.26.1 Roche Holding AG Details
        2.26.2 Roche Holding AG Major Business
        2.26.3 Roche Holding AG Personalized Medicine and Epigenomics Product and Solutions
        2.26.4 Roche Holding AG Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2019-2021)
        2.26.5 Roche Holding AG Recent Developments and Future Plans
    2.27 Rubicon Genomics
        2.27.1 Rubicon Genomics Details
        2.27.2 Rubicon Genomics Major Business
        2.27.3 Rubicon Genomics Personalized Medicine and Epigenomics Product and Solutions
        2.27.4 Rubicon Genomics Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2019-2021)
        2.27.5 Rubicon Genomics Recent Developments and Future Plans
    2.28 Takeda Pharmaceutical Company Limited
        2.28.1 Takeda Pharmaceutical Company Limited Details
        2.28.2 Takeda Pharmaceutical Company Limited Major Business
        2.28.3 Takeda Pharmaceutical Company Limited Personalized Medicine and Epigenomics Product and Solutions
        2.28.4 Takeda Pharmaceutical Company Limited Personalized Medicine and Epigenomics Revenue, Gross Margin and Market Share (2019-2021)
        2.28.5 Takeda Pharmaceutical Company Limited Recent Developments and Future Plans
3 Market Competition, by Players
    3.1 Global Personalized Medicine and Epigenomics Revenue and Share by Players (2019-2021)
    3.2 Market Concentration Rate
        3.2.1 Top 5 Personalized Medicine and Epigenomics Players Market Share
        3.2.2 Top 10 Personalized Medicine and Epigenomics Players Market Share
        3.2.3 Market Competition Trend
    3.3 Personalized Medicine and Epigenomics Players Head Office, Products and Services Provided
    3.4 Mergers & Acquisitions
    3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
    4.1 Global Personalized Medicine and Epigenomics Revenue and Market Share by Type (2016-2021)
    4.2 Global Personalized Medicine and Epigenomics Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
    5.1 Global Personalized Medicine and Epigenomics Revenue Market Share by Application (2016-2021)
    5.2 Personalized Medicine and Epigenomics Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
    6.1 North America Personalized Medicine and Epigenomics Revenue by Type (2016-2026)
    6.2 North America Personalized Medicine and Epigenomics Revenue by Application (2016-2026)
    6.3 North America Personalized Medicine and Epigenomics Market Size by Country
        6.3.1 North America Personalized Medicine and Epigenomics Revenue by Country (2016-2026)
        6.3.2 United States Personalized Medicine and Epigenomics Market Size and Forecast (2016-2026)
        6.3.3 Canada Personalized Medicine and Epigenomics Market Size and Forecast (2016-2026)
        6.3.4 Mexico Personalized Medicine and Epigenomics Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
    7.1 Europe Personalized Medicine and Epigenomics Revenue by Type (2016-2026)
    7.2 Europe Personalized Medicine and Epigenomics Revenue by Application (2016-2026)
    7.3 Europe Personalized Medicine and Epigenomics Market Size by Country
        7.3.1 Europe Personalized Medicine and Epigenomics Revenue by Country (2016-2026)
        7.3.2 Germany Personalized Medicine and Epigenomics Market Size and Forecast (2016-2026)
        7.3.3 France Personalized Medicine and Epigenomics Market Size and Forecast (2016-2026)
        7.3.4 United Kingdom Personalized Medicine and Epigenomics Market Size and Forecast (2016-2026)
        7.3.5 Russia Personalized Medicine and Epigenomics Market Size and Forecast (2016-2026)
        7.3.6 Italy Personalized Medicine and Epigenomics Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific Personalized Medicine and Epigenomics Revenue by Type (2016-2026)
    8.2 Asia-Pacific Personalized Medicine and Epigenomics Revenue by Application (2016-2026)
    8.3 Asia-Pacific Personalized Medicine and Epigenomics Market Size by Region
        8.3.1 Asia-Pacific Personalized Medicine and Epigenomics Revenue by Region (2016-2026)
        8.3.2 China Personalized Medicine and Epigenomics Market Size and Forecast (2016-2026)
        8.3.3 Japan Personalized Medicine and Epigenomics Market Size and Forecast (2016-2026)
        8.3.4 South Korea Personalized Medicine and Epigenomics Market Size and Forecast (2016-2026)
        8.3.5 India Personalized Medicine and Epigenomics Market Size and Forecast (2016-2026)
        8.3.6 Southeast Asia Personalized Medicine and Epigenomics Market Size and Forecast (2016-2026)
        8.3.7 Australia Personalized Medicine and Epigenomics Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
    9.1 South America Personalized Medicine and Epigenomics Revenue by Type (2016-2026)
    9.2 South America Personalized Medicine and Epigenomics Revenue by Application (2016-2026)
    9.3 South America Personalized Medicine and Epigenomics Market Size by Country
        9.3.1 South America Personalized Medicine and Epigenomics Revenue by Country (2016-2026)
        9.3.2 Brazil Personalized Medicine and Epigenomics Market Size and Forecast (2016-2026)
        9.3.3 Argentina Personalized Medicine and Epigenomics Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa Personalized Medicine and Epigenomics Revenue by Type (2016-2026)
    10.2 Middle East & Africa Personalized Medicine and Epigenomics Revenue by Application (2016-2026)
    10.3 Middle East & Africa Personalized Medicine and Epigenomics Market Size by Country
        10.3.1 Middle East & Africa Personalized Medicine and Epigenomics Revenue by Country (2016-2026)
        10.3.2 Turkey Personalized Medicine and Epigenomics Market Size and Forecast (2016-2026)
        10.3.3 Saudi Arabia Personalized Medicine and Epigenomics Market Size and Forecast (2016-2026)
        10.3.4 UAE Personalized Medicine and Epigenomics Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer

List of Tables Table 1. Global Personalized Medicine and Epigenomics Revenue by Type, (USD Million), 2020 VS 2021 VS 2026 Table 2. Global Personalized Medicine and Epigenomics Revenue by Application, (USD Million), 2020 VS 2021 VS 2026 Table 3. Global Market Personalized Medicine and Epigenomics Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026) Table 4. Global Personalized Medicine and Epigenomics Revenue (USD Million) by Region (2016-2021) Table 5. Global Personalized Medicine and Epigenomics Revenue Market Share by Region (2021-2026) Table 6. Abbott Laboratories Corporate Information, Head Office, and Major Competitors Table 7. Abbott Laboratories Major Business Table 8. Abbott Laboratories Personalized Medicine and Epigenomics Product and Solutions Table 9. Abbott Laboratories Personalized Medicine and Epigenomics Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 10. Affymetrix Corporate Information, Head Office, and Major Competitors Table 11. Affymetrix Major Business Table 12. Affymetrix Personalized Medicine and Epigenomics Product and Solutions Table 13. Affymetrix Personalized Medicine and Epigenomics Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 14. Agilent Technologies Corporate Information, Head Office, and Major Competitors Table 15. Agilent Technologies Major Business Table 16. Agilent Technologies Personalized Medicine and Epigenomics Product and Solutions Table 17. Agilent Technologies Personalized Medicine and Epigenomics Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 18. Astellas Pharmaceuticals Corporate Information, Head Office, and Major Competitors Table 19. Astellas Pharmaceuticals Major Business Table 20. Astellas Pharmaceuticals Personalized Medicine and Epigenomics Product and Solutions Table 21. Astellas Pharmaceuticals Personalized Medicine and Epigenomics Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 22. BAYER AG Corporate Information, Head Office, and Major Competitors Table 23. BAYER AG Major Business Table 24. BAYER AG Personalized Medicine and Epigenomics Product and Solutions Table 25. BAYER AG Personalized Medicine and Epigenomics Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 26. Bio Vision Corporate Information, Head Office, and Major Competitors Table 27. Bio Vision Major Business Table 28. Bio Vision Personalized Medicine and Epigenomics Product and Solutions Table 29. Bio Vision Personalized Medicine and Epigenomics Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 30. Celgene Corp. Corporate Information, Head Office, and Major Competitors Table 31. Celgene Corp. Major Business Table 32. Celgene Corp. Personalized Medicine and Epigenomics Product and Solutions Table 33. Celgene Corp. Personalized Medicine and Epigenomics Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 34. Emd Millipore Corporate Information, Head Office, and Major Competitors Table 35. Emd Millipore Major Business Table 36. Emd Millipore Personalized Medicine and Epigenomics Product and Solutions Table 37. Emd Millipore Personalized Medicine and Epigenomics Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 38. Epigenomics AG Corporate Information, Head Office, and Major Competitors Table 39. Epigenomics AG Major Business Table 40. Epigenomics AG Personalized Medicine and Epigenomics Product and Solutions Table 41. Epigenomics AG Personalized Medicine and Epigenomics Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 42. Epigentex Corporate Information, Head Office, and Major Competitors Table 43. Epigentex Major Business Table 44. Epigentex Personalized Medicine and Epigenomics Product and Solutions Table 45. Epigentex Personalized Medicine and Epigenomics Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 46. Envivo Pharmaceuticals (Forum Pharmaceutricals) Corporate Information, Head Office, and Major Competitors Table 47. Envivo Pharmaceuticals (Forum Pharmaceutricals) Major Business Table 48. Envivo Pharmaceuticals (Forum Pharmaceutricals) Personalized Medicine and Epigenomics Product and Solutions Table 49. Envivo Pharmaceuticals (Forum Pharmaceutricals) Personalized Medicine and Epigenomics Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 50. Gilead Sciences Corporate Information, Head Office, and Major Competitors Table 51. Gilead Sciences Major Business Table 52. Gilead Sciences Personalized Medicine and Epigenomics Product and Solutions Table 53. Gilead Sciences Personalized Medicine and Epigenomics Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 54. Glaxosmithkline Corporate Information, Head Office, and Major Competitors Table 55. Glaxosmithkline Major Business Table 56. Glaxosmithkline Personalized Medicine and Epigenomics Product and Solutions Table 57. Glaxosmithkline Personalized Medicine and Epigenomics Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 58. Illumina Inc. Corporate Information, Head Office, and Major Competitors Table 59. Illumina Inc. Major Business Table 60. Illumina Inc. Personalized Medicine and Epigenomics Product and Solutions Table 61. Illumina Inc. Personalized Medicine and Epigenomics Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 62. Johnson & Johnson Corporate Information, Head Office, and Major Competitors Table 63. Johnson & Johnson Major Business Table 64. Johnson & Johnson Personalized Medicine and Epigenomics Product and Solutions Table 65. Johnson & Johnson Personalized Medicine and Epigenomics Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 66. Karus Therapeutics Limited Corporate Information, Head Office, and Major Competitors Table 67. Karus Therapeutics Limited Major Business Table 68. Karus Therapeutics Limited Personalized Medicine and Epigenomics Product and Solutions Table 69. Karus Therapeutics Limited Personalized Medicine and Epigenomics Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 70. Laboratory Corp. Of America Holdings Corporate Information, Head Office, and Major Competitors Table 71. Laboratory Corp. Of America Holdings Major Business Table 72. Laboratory Corp. Of America Holdings Personalized Medicine and Epigenomics Product and Solutions Table 73. Laboratory Corp. Of America Holdings Personalized Medicine and Epigenomics Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 74. LES Laboratoires Servier Corporate Information, Head Office, and Major Competitors Table 75. LES Laboratoires Servier Major Business Table 76. LES Laboratoires Servier Personalized Medicine and Epigenomics Product and Solutions Table 77. LES Laboratoires Servier Personalized Medicine and Epigenomics Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 78. Merck Corporate Information, Head Office, and Major Competitors Table 79. Merck Major Business Table 80. Merck Personalized Medicine and Epigenomics Product and Solutions Table 81. Merck Personalized Medicine and Epigenomics Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 82. Naturewise Biotech & Medicals Corp. Corporate Information, Head Office, and Major Competitors Table 83. Naturewise Biotech & Medicals Corp. Major Business Table 84. Naturewise Biotech & Medicals Corp. Personalized Medicine and Epigenomics Product and Solutions Table 85. Naturewise Biotech & Medicals Corp. Personalized Medicine and Epigenomics Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 86. Novartis Pharma AG Corporate Information, Head Office, and Major Competitors Table 87. Novartis Pharma AG Major Business Table 88. Novartis Pharma AG Personalized Medicine and Epigenomics Product and Solutions Table 89. Novartis Pharma AG Personalized Medicine and Epigenomics Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 90. Oncolys Biopharma Inc. Corporate Information, Head Office, and Major Competitors Table 91. Oncolys Biopharma Inc. Major Business Table 92. Oncolys Biopharma Inc. Personalized Medicine and Epigenomics Product and Solutions Table 93. Oncolys Biopharma Inc. Personalized Medicine and Epigenomics Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 94. Orchid Chemicals & Pharmaceuticals Limited Corporate Information, Head Office, and Major Competitors Table 95. Orchid Chemicals & Pharmaceuticals Limited Major Business Table 96. Orchid Chemicals & Pharmaceuticals Limited Personalized Medicine and Epigenomics Product and Solutions Table 97. Orchid Chemicals & Pharmaceuticals Limited Personalized Medicine and Epigenomics Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 98. Progen Pharmaceuticals Limited Corporate Information, Head Office, and Major Competitors Table 99. Progen Pharmaceuticals Limited Major Business Table 100. Progen Pharmaceuticals Limited Personalized Medicine and Epigenomics Product and Solutions Table 101. Progen Pharmaceuticals Limited Personalized Medicine and Epigenomics Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 102. Quest Diagnostics Corporate Information, Head Office, and Major Competitors Table 103. Quest Diagnostics Major Business Table 104. Quest Diagnostics Personalized Medicine and Epigenomics Product and Solutions Table 105. Quest Diagnostics Personalized Medicine and Epigenomics Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 106. Roche Holding AG Corporate Information, Head Office, and Major Competitors Table 107. Roche Holding AG Major Business Table 108. Roche Holding AG Personalized Medicine and Epigenomics Product and Solutions Table 109. Roche Holding AG Personalized Medicine and Epigenomics Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 110. Rubicon Genomics Corporate Information, Head Office, and Major Competitors Table 111. Rubicon Genomics Major Business Table 112. Rubicon Genomics Personalized Medicine and Epigenomics Product and Solutions Table 113. Rubicon Genomics Personalized Medicine and Epigenomics Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 114. Takeda Pharmaceutical Company Limited Corporate Information, Head Office, and Major Competitors Table 115. Takeda Pharmaceutical Company Limited Major Business Table 116. Takeda Pharmaceutical Company Limited Personalized Medicine and Epigenomics Product and Solutions Table 117. Takeda Pharmaceutical Company Limited Personalized Medicine and Epigenomics Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 118. Global Personalized Medicine and Epigenomics Revenue (USD Million) by Players (2019-2021) Table 119. Global Personalized Medicine and Epigenomics Revenue Share by Players (2019-2021) Table 120. Breakdown of Personalized Medicine and Epigenomics by Company Type (Tier 1, Tier 2 and Tier 3) Table 121. Personalized Medicine and Epigenomics Players Head Office, Products and Services Provided Table 122. Personalized Medicine and Epigenomics Mergers & Acquisitions in the Past Five Years Table 123. Personalized Medicine and Epigenomics New Entrants and Expansion Plans Table 124. Global Personalized Medicine and Epigenomics Revenue (USD Million) by Type (2016-2021) Table 125. Global Personalized Medicine and Epigenomics Revenue Share by Type (2016-2021) Table 126. Global Personalized Medicine and Epigenomics Revenue Forecast by Type (2021-2026) Table 127. Global Personalized Medicine and Epigenomics Revenue by Application (2016-2021) Table 128. Global Personalized Medicine and Epigenomics Revenue Forecast by Application (2021-2026) Table 129. North America Personalized Medicine and Epigenomics Revenue by Type (2016-2021) & (USD Million) Table 130. North America Personalized Medicine and Epigenomics Revenue by Type (2021-2026) & (USD Million) Table 131. North America Personalized Medicine and Epigenomics Revenue by Application (2016-2021) & (USD Million) Table 132. North America Personalized Medicine and Epigenomics Revenue by Application (2021-2026) & (USD Million) Table 133. North America Personalized Medicine and Epigenomics Revenue by Country (2016-2021) & (USD Million) Table 134. North America Personalized Medicine and Epigenomics Revenue by Country (2021-2026) & (USD Million) Table 135. Europe Personalized Medicine and Epigenomics Revenue by Type (2016-2021) & (USD Million) Table 136. Europe Personalized Medicine and Epigenomics Revenue by Type (2021-2026) & (USD Million) Table 137. Europe Personalized Medicine and Epigenomics Revenue by Application (2016-2021) & (USD Million) Table 138. Europe Personalized Medicine and Epigenomics Revenue by Application (2021-2026) & (USD Million) Table 139. Europe Personalized Medicine and Epigenomics Revenue by Country (2016-2021) & (USD Million) Table 140. Europe Personalized Medicine and Epigenomics Revenue by Country (2021-2026) & (USD Million) Table 141. Asia-Pacific Personalized Medicine and Epigenomics Revenue by Type (2016-2021) & (USD Million) Table 142. Asia-Pacific Personalized Medicine and Epigenomics Revenue by Type (2021-2026) & (USD Million) Table 143. Asia-Pacific Personalized Medicine and Epigenomics Revenue by Application (2016-2021) & (USD Million) Table 144. Asia-Pacific Personalized Medicine and Epigenomics Revenue by Application (2021-2026) & (USD Million) Table 145. Asia-Pacific Personalized Medicine and Epigenomics Revenue by Region (2016-2021) & (USD Million) Table 146. Asia-Pacific Personalized Medicine and Epigenomics Revenue by Region (2021-2026) & (USD Million) Table 147. South America Personalized Medicine and Epigenomics Revenue by Type (2016-2021) & (USD Million) Table 148. South America Personalized Medicine and Epigenomics Revenue by Type (2021-2026) & (USD Million) Table 149. South America Personalized Medicine and Epigenomics Revenue by Application (2016-2021) & (USD Million) Table 150. South America Personalized Medicine and Epigenomics Revenue by Application (2021-2026) & (USD Million) Table 151. South America Personalized Medicine and Epigenomics Revenue by Country (2016-2021) & (USD Million) Table 152. South America Personalized Medicine and Epigenomics Revenue by Country (2021-2026) & (USD Million) Table 153. Middle East & Africa Personalized Medicine and Epigenomics Revenue by Type (2016-2021) & (USD Million) Table 154. Middle East & Africa Personalized Medicine and Epigenomics Revenue by Type (2021-2026) & (USD Million) Table 155. Middle East & Africa Personalized Medicine and Epigenomics Revenue by Application (2016-2021) & (USD Million) Table 156. Middle East & Africa Personalized Medicine and Epigenomics Revenue by Application (2021-2026) & (USD Million) Table 157. Middle East & Africa Personalized Medicine and Epigenomics Revenue by Country (2016-2021) & (USD Million) Table 158. Middle East & Africa Personalized Medicine and Epigenomics Revenue by Country (2021-2026) & (USD Million) List of Figures Figure 1. Personalized Medicine and Epigenomics Picture Figure 2. Global Personalized Medicine and Epigenomics Revenue Market Share by Type in 2020 Figure 3. Reagents Figure 4. Kits Figure 5. Instruments Figure 6. Enzymes Figure 7. Services Figure 8. Personalized Medicine and Epigenomics Revenue Market Share by Application in 2020 Figure 9. Oncology Picture Figure 10. Non-Oncology Picture Figure 11. Cancer Drug Technology Picture Figure 12. Global Personalized Medicine and Epigenomics Revenue, (USD Million): 2020 VS 2021 VS 2026 Figure 13. Global Personalized Medicine and Epigenomics Revenue and Forecast (2016-2026) & (USD Million) Figure 14. Global Personalized Medicine and Epigenomics Revenue Market Share by Region (2016-2026) Figure 15. Global Personalized Medicine and Epigenomics Revenue Market Share by Region in 2020 Figure 16. North America Personalized Medicine and Epigenomics Revenue (USD Million) and Growth Rate (2016-2026) Figure 17. Europe Personalized Medicine and Epigenomics Revenue (USD Million) and Growth Rate (2016-2026) Figure 18. Asia-Pacific Personalized Medicine and Epigenomics Revenue (USD Million) and Growth Rate (2016-2026) Figure 19. South America Personalized Medicine and Epigenomics Revenue (USD Million) and Growth Rate (2016-2026) Figure 20. Personalized Medicine and Epigenomics Market Drivers Figure 21. Personalized Medicine and Epigenomics Market Restraints Figure 22. Personalized Medicine and Epigenomics Market Trends Figure 23. Abbott Laboratories Recent Developments and Future Plans Figure 24. Affymetrix Recent Developments and Future Plans Figure 25. Agilent Technologies Recent Developments and Future Plans Figure 26. Astellas Pharmaceuticals Recent Developments and Future Plans Figure 27. BAYER AG Recent Developments and Future Plans Figure 28. Bio Vision Recent Developments and Future Plans Figure 29. Celgene Corp. Recent Developments and Future Plans Figure 30. Emd Millipore Recent Developments and Future Plans Figure 31. Epigenomics AG Recent Developments and Future Plans Figure 32. Epigentex Recent Developments and Future Plans Figure 33. Envivo Pharmaceuticals (Forum Pharmaceutricals) Recent Developments and Future Plans Figure 34. Gilead Sciences Recent Developments and Future Plans Figure 35. Glaxosmithkline Recent Developments and Future Plans Figure 36. Illumina Inc. Recent Developments and Future Plans Figure 37. Johnson & Johnson Recent Developments and Future Plans Figure 38. Karus Therapeutics Limited Recent Developments and Future Plans Figure 39. Laboratory Corp. Of America Holdings Recent Developments and Future Plans Figure 40. LES Laboratoires Servier Recent Developments and Future Plans Figure 41. Merck Recent Developments and Future Plans Figure 42. Naturewise Biotech & Medicals Corp. Recent Developments and Future Plans Figure 43. Novartis Pharma AG Recent Developments and Future Plans Figure 44. Oncolys Biopharma Inc. Recent Developments and Future Plans Figure 45. Orchid Chemicals & Pharmaceuticals Limited Recent Developments and Future Plans Figure 46. Orchid Chemicals & Pharmaceuticals Limited Recent Developments and Future Plans Figure 47. Progen Pharmaceuticals Limited Recent Developments and Future Plans Figure 48. Quest Diagnostics Recent Developments and Future Plans Figure 49. Roche Holding AG Recent Developments and Future Plans Figure 50. Rubicon Genomics Recent Developments and Future Plans Figure 51. Takeda Pharmaceutical Company Limited Recent Developments and Future Plans Figure 52. Global Personalized Medicine and Epigenomics Revenue Share by Players in 2020 Figure 53. Personalized Medicine and Epigenomics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) Figure 54. Global Top 3 Players Personalized Medicine and Epigenomics Revenue Market Share in 2020 Figure 55. Global Top 10 Players Personalized Medicine and Epigenomics Revenue Market Share in 2020 Figure 56. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021) Figure 57. Global Personalized Medicine and Epigenomics Revenue Share by Type in 2020 Figure 58. Global Personalized Medicine and Epigenomics Market Share Forecast by Type (2021-2026) Figure 59. Global Personalized Medicine and Epigenomics Revenue Share by Application in 2020 Figure 60. Global Personalized Medicine and Epigenomics Market Share Forecast by Application (2021-2026) Figure 61. North America Personalized Medicine and Epigenomics Sales Market Share by Type (2016-2026) Figure 62. North America Personalized Medicine and Epigenomics Sales Market Share by Application (2016-2026) Figure 63. North America Personalized Medicine and Epigenomics Revenue Market Share by Country (2016-2026) Figure 64. United States Personalized Medicine and Epigenomics Revenue and Growth Rate (2016-2026) & (USD Million) Figure 65. Canada Personalized Medicine and Epigenomics Revenue and Growth Rate (2016-2026) & (USD Million) Figure 66. Mexico Personalized Medicine and Epigenomics Revenue and Growth Rate (2016-2026) & (USD Million) Figure 67. Europe Personalized Medicine and Epigenomics Sales Market Share by Type (2016-2026) Figure 68. Europe Personalized Medicine and Epigenomics Sales Market Share by Application (2016-2026) Figure 69. Europe Personalized Medicine and Epigenomics Revenue Market Share by Country (2016-2026) Figure 70. Germany Personalized Medicine and Epigenomics Revenue and Growth Rate (2016-2026) & (USD Million) Figure 71. France Personalized Medicine and Epigenomics Revenue and Growth Rate (2016-2026) & (USD Million) Figure 72. United Kingdom Personalized Medicine and Epigenomics Revenue and Growth Rate (2016-2026) & (USD Million) Figure 73. Russia Personalized Medicine and Epigenomics Revenue and Growth Rate (2016-2026) & (USD Million) Figure 74. Italy Personalized Medicine and Epigenomics Revenue and Growth Rate (2016-2026) & (USD Million) Figure 75. Asia-Pacific Personalized Medicine and Epigenomics Sales Market Share by Type (2016-2026) Figure 76. Asia-Pacific Personalized Medicine and Epigenomics Sales Market Share by Application (2016-2026) Figure 77. Asia-Pacific Personalized Medicine and Epigenomics Revenue Market Share by Region (2016-2026) Figure 78. China Personalized Medicine and Epigenomics Revenue and Growth Rate (2016-2026) & (USD Million) Figure 79. Japan Personalized Medicine and Epigenomics Revenue and Growth Rate (2016-2026) & (USD Million) Figure 80. South Korea Personalized Medicine and Epigenomics Revenue and Growth Rate (2016-2026) & (USD Million) Figure 81. India Personalized Medicine and Epigenomics Revenue and Growth Rate (2016-2026) & (USD Million) Figure 82. Southeast Asia Personalized Medicine and Epigenomics Revenue and Growth Rate (2016-2026) & (USD Million) Figure 83. Australia Personalized Medicine and Epigenomics Revenue and Growth Rate (2016-2026) & (USD Million) Figure 84. South America Personalized Medicine and Epigenomics Sales Market Share by Type (2016-2026) Figure 85. South America Personalized Medicine and Epigenomics Sales Market Share by Application (2016-2026) Figure 86. South America Personalized Medicine and Epigenomics Revenue Market Share by Country (2016-2026) Figure 87. Brazil Personalized Medicine and Epigenomics Revenue and Growth Rate (2016-2026) & (USD Million) Figure 88. Argentina Personalized Medicine and Epigenomics Revenue and Growth Rate (2016-2026) & (USD Million) Figure 89. Middle East and Africa Personalized Medicine and Epigenomics Sales Market Share by Type (2016-2026) Figure 90. Middle East and Africa Personalized Medicine and Epigenomics Sales Market Share by Application (2016-2026) Figure 91. Middle East and Africa Personalized Medicine and Epigenomics Revenue Market Share by Country (2016-2026) Figure 92. Turkey Personalized Medicine and Epigenomics Revenue and Growth Rate (2016-2026) & (USD Million) Figure 93. Saudi Arabia Personalized Medicine and Epigenomics Revenue and Growth Rate (2016-2026) & (USD Million) Figure 94. UAE Personalized Medicine and Epigenomics Revenue and Growth Rate (2016-2026) & (USD Million) Figure 95. Methodology Figure 96. Research Process and Data Source

Qualitative Analysis covers:

  • Industry Status and Trends
  • Manufacturer/Company profiles, manufacturing base distribution, sales areas, product introduction, main business, market position and their competitors.
  • Product Development, Technology, Price, Cost, Manufacturing Process and Trends
  • Market segment by regions, types, applications and forecast
  • Market opportunities, potential, government policies and influence factors.
     

Quantitative Analysis covers:

  • Market size (value, sales/output, historical data and forecasts)
  • Sales/output/capacity, revenue, price, gross margin, market share, for top players. Through interviewing each manufacturers,  distributors, traders, dealers and buyers etc.
  • Cost structure, proportion, price trend, gross margin and trend, status and trend, for 10 years
  • Market size by types, regions, applications for 10 years
  • Market forecast based on the potential demand from downstream clients/buyers, government, influence factors and the total economic indication, maybe occur in following years.
     

Data Sources:

Methodology

 

Publisher: GlobalInfoResearch
Chat with us